YBX1 and Thrombocytopenia: For instance, the pronounced hematological adverse effects, particularly thrombocytopenia (LaFargue et al., 2019) may be explained by the role YB-1 in megakaryocyte versus erythroid differentiation (Bhullar and Sollars, 2011).